Tenax Therapeutics Inc banner

Tenax Therapeutics Inc
NASDAQ:TENX

Watchlist Manager
Tenax Therapeutics Inc Logo
Tenax Therapeutics Inc
NASDAQ:TENX
Watchlist
Price: 11.65 USD -3.72% Market Closed
Market Cap: $72.7m

Profitability Summary

Tenax Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Tenax Therapeutics Inc

Margins Comparison
Tenax Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Tenax Therapeutics Inc
NASDAQ:TENX
68.8m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
402.2B USD
Loading...
Loading...
US
Astria Therapeutics Inc
NASDAQ:ATXS
326.4B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
206.8B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
182.9B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
122.6B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.3B USD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
70.2B AUD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Tenax Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Tenax Therapeutics Inc
NASDAQ:TENX
68.8m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
402.2B USD
Loading...
Loading...
Loading...
Loading...
US
Astria Therapeutics Inc
NASDAQ:ATXS
326.4B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
206.8B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
182.9B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
122.6B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.3B USD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
70.2B AUD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Tenax Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett